Clinical Trials Browser

Terminated × toripalimab × 90 days × Clear all

NCT04651127 2026-03-10

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

Phase 1/2 Terminated

Uterine Cervical Neoplasms

NCT06114940 2026-03-05

PLUTO

Phase 2 Terminated

Carcinoma, Renal Cell

NCT04418648 2026-02-04

Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

Phase 2 Terminated

Small Cell Lung Cancer Limited Stage